This website uses technical, analytics and third party cookies. By continuing to browse, you accept our cookies.
Follow us on
AIFA publishes the results of the monitoring related to monoclonal antibodies for the treatment of COVID-19 currently available.
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
The book “Il Tavolo Tecnico Indisponibilità” (TTI, technical panel for unavailability) has been presented, published by the Istituto Poligrafico dello Stato (IPZS) in collaboration with AIFA.
The “European Antibiotic Awareness Day” (EAAD) promoted by the World Health Organization (WHO) is celebrated on 18 November; this year its theme is represented by the slogan “Spread awareness, stop resistance”.
Withdrawals and bans on use
Notices on shortages
Access to medicinal products
Safety of medicinal products
Quality and Inspections
Research and Clinical trials
Pricing and reimbursement
Consumption and pharmaceutical expenditure
Innovation and planning
Information and communication
Find here more detailed information and documents
Report a suspected adverse reaction online
FarmaciLine – Independent Pharmaceuticals Information Centre
Equivalent medicinal products
Requests for authorisation of conferences and meetings
National Observatory on Clinical Trials
Medicinal products authorised in 2020
GCP inspections in 2020
Clinical trials authorised in 2020
GVP inspections 2020
GMP inspections (Medicinal products) 2020
Orphan drugs authorised in 2019
Riunione Commissione Tecnico Scientifica (CTS)
Riunione Comitato Prezzi e Rimborso (CPR)